Sloning and Research & Innovation Japan Announce Distribution Partnership
News Jul 20, 2007
Sloning Biotechnology has announced a distribution partnership with Research & Innovation Japan Inc. (RIJ).
RIJ will exclusively market and sell Sloning´s gene synthesis service (Slonomics™) and the product family of gene mutant libraries (Slonomax™) in Japan.
“We are very pleased that RIJ will join our global network of qualified distributors. Their technological strength and market awareness makes RIJ the ideal partner to co-develop the Japanese market.” stated Thomas Matthes, the company CBO.
Kiyohiko Hirasawa, founder and CEO of RIJ said “Sloning´s products and services perfectly addressing the current demand in genomics research and protein engineering. We are looking forward to represent Sloning in Japan”.
New Cell-weighing Technique Helps Predict How Drugs Affect Cancer CellsNews
Researchers at MIT have now shown that they can use a new type of measurement to predict how drugs will affect cancer cells taken from multiple-myeloma patients.READ MORE
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Defects in Cell’s ‘Waste Disposal System’ Linked to Parkinson’sNews
An international study has shed new light on the genetic factors associated with Parkinson’s disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of this common neurodegenerative disorder.READ MORE